2016 Genetics and mental health Pharmaceuticals 
Mad in America
JANUARY 24, 2024
Hailed as the future of mental health care, it conjures images of medical interventions as carefully planned and executed military operations, striking with lethal accuracy at the heart of mental suffering while minimising collateral damage. Photo by A.T.
Mad in America
NOVEMBER 13, 2023
Schatzberg has served as a consultant to or received honoraria from Abbott, Bristol-Myers Squibb, Corcept Therapeutics, Forest Laboratories, Janssen, Eli Lilly, Merck, Mitsubishi Pharmaceuticals, Organon, ParkeDavis, Pfizer, Pharmacia–Upjohn, Sanofi, Scirex, SmithKline Beecham, Solvay, and Wyeth–Ayerst. 695 This is sickening.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
SEPTEMBER 20, 2024
I didn’t know Wallace was a poster boy for antidepressant withdrawal because I didn’t know that antidepressant withdrawal was common, or that I would be experiencing it myself and understanding firsthand the hellish bodily and mental feelings that make one long for death, for everything to stop. It did not look good.
Mad in America
APRIL 16, 2024
As an example, the Danish Board of Health has warned that adding a benzodiazepine to a neuroleptic increases mortality by 50-65%. Genetic association studies have come up empty-handed and so have brain imaging studies, which are generally highly flawed. Deadly medicines and organised crime: How big pharma has corrupted health care.
Mad in America
APRIL 24, 2024
As a Professor of Medical Anthropology at Harvard University’s Department of Global Health and Social Medicine and a Professor of Psychiatry at Harvard Medical School, Kleinman has profoundly influenced how medical professionals understand the interplay between culture, illness, and healing. Listen to the audio of the interview here.
Expert insights. Personalized for you.
122 
Let's personalize your content